Back to Journals » International Journal of Nanomedicine » Volume 13

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Total article views   Abstract views HTML views PDF downloads Totals
6,225 Dovepress* 3,707 1,351+ 1,375 5,058
PubMed Central* 0 1,167 374 1,167
Totals 3,707 2,518 1,749 6,225
*Since 29 May 2018
+Since July 2016

View citations on PubMed Central and Google Scholar